Clinical experience with subcutaneous venous reservoirs in cancer patients;Experiencia clínica con reservorios venosos subcutáneos en pacientes oncológicos

Clinical and Translational Oncology

Volumn 6, Issue 1, 2004, Pages 30-36

  Ibáñez, Antonio Cózar ^a   Del Olmo Escribano, Miguel ^a   Montesinos, José Martín Moreno ^a   Armenteros, Francisco Jiménez ^a   Del Carmen Quesada Peinado, María ^a  

^a Serv Cirugia Gen Aparato Digestivo   (Spain)

Author keywords

Indications and complications; Subclavian percutaneous puncture; Subcutaneous venous reservoirs

Indexed keywords

EID: 84873336327     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cózar Ibáñez A, del Olmo Escribano M, Navarrete Sánchez I, Cosano Álvarez A, Sánchez Rovira P, Moreno Jiménez MA. Fractura espontánea y migración intravascular del catéter en los reservorios venosos subcutáneos. Cir Esp 1999;65(2):163-5.
2. Del Olmo Escribano M, Soto Blanco JM, García Jiménez M, Lozano Barriuso A, Martínez Muro JL. Reservorios venosos subcutáneos. Técnica y resultados. Cir Esp 1992;52(4):264-8.
3. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92(4):706-12. (Pubitemid 13091564)
4. Freytes CO. Indications and complications of intravenous devices for chemotherapy. Curr Opin Oncol 2000; 12(4):303-7. (Pubitemid 32043966)
5. Sotir MJ, Lewis C, Bisher EW, Ray SM, Soucie JM, Blumberg HM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol 1999;20(3):187-91.
6. Whitman ED. Complications associated with the use of central venous access devices. Curr Probl Surg 1996; 33(4):309-78.
7. Bow EJ, Kilpatrick MG, Clinch JJ. Totally implantable venous access ports systems for patients receiving chemotherapy for solid malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 1999;17(4): 1267-72.
8. Rosenblum DI, Geisinger MA, Newman JS, et al. Use of subcutaneous venous access ports to treat refractory ascites. J Vasc Interv Radiol 2001;12(11):1343-6. (Pubitemid 33069798)
9. Di Carlo I, Cordio S, La Greca G, et al. Totally implantable venous access devices implanted surgically: A retrospective study on early and late complications. Arch Surg 2001;136(9):1050-3. (Pubitemid 32982996)
10. D'Angelo F, Ramacciato G, Caramitti A, et al. Totally implantable venous access systems. Analysis of complications. Minerva Chir 1997;52(7-8):937-42. (Pubitemid 27466385)
11. Minassian VA, Sood AK, Lowe P, Sorosky JI, Al-Jurf AS, Buller RE. Longterm central venous access in gynaecologic cancer patients. J Am Coll Surg 2000;191(4): 403-9.
12. Kuriakose P, Colon-Otero G, Paz-Fumagalli R. Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: A 5- year single-institution retrospective study. Vasc Interv Radiol 2002;13:179-84. (Pubitemid 34160380)
13. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 1997;79(8):1635-40. (Pubitemid 27154800)
14. Petersen J, Delaney JH, Brakstad MT, Rowbotham RK, Bagley CM. Silicone venous access devices postioned with their tips high in the superior vena cava are more likely to malfunction. Am J Surg 1999;178(1):38-41. (Pubitemid 29375060)
15. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993; 119(12):1168-74. (Pubitemid 23361446)
16. Douard MC, Arlet G, Longuet P, et al. Diagnosis of venous access port-related infections. Clin Infect Dis 1999; 29(5):1197-202. (Pubitemid 30265639)
17. Longuet P, Douard MC, Arlet G, Molina JM, Benoit C, Leport C. Venous access port-related bacteriemia in patients with acquired immunodeficiency syndrome or cancer: The reservoir as diagnostic and therapeutic tool. Clin Infect Dis 2001;32(12):1776-83. (Pubitemid 32532008)
18. Xiang DZ, Verbeken EK, Van Lommel AT, Stas M, De Wever I. Composition and formation of the sleeve enveloping a central venous catheter. J Vasc Surg 1998;28(2): 260-71. (Pubitemid 28377978)
19. Hadaway LC. Managing vascular access device occlusions, part 1. Nursing 2000;30(7):20.
20. Ponec D, Irwin D, Haire WD, Hill PA, Li X, McCluskey ER. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial-The Cardiovascular thrombolytic to open occluded lines (COOL) efficacy trial. J Vasc Inter Radiol 2001;12(8): 951-5. (Pubitemid 32756865)